161 related articles for article (PubMed ID: 30265714)
21. Molecular surveillance of anti-malarial resistance Pfdhfr and Pfdhps polymorphisms in African and Southeast Asia Plasmodium falciparum imported parasites to Wuhan, China.
Jiang T; Cheng W; Yao Y; Tan H; Wu K; Li J
Malar J; 2020 Nov; 19(1):434. PubMed ID: 33238987
[TBL] [Abstract][Full Text] [Related]
22. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy.
Ogouyèmi-Hounto A; Ndam NT; Kinde Gazard D; d'Almeida S; Koussihoude L; Ollo E; Azagnandji C; Bello M; Chippaux JP; Massougbodji A
Malar J; 2013 May; 12():147. PubMed ID: 23634705
[TBL] [Abstract][Full Text] [Related]
24. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
[TBL] [Abstract][Full Text] [Related]
25. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
[TBL] [Abstract][Full Text] [Related]
26. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
[TBL] [Abstract][Full Text] [Related]
27. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.
Ogouyèmi-Hounto A; Ndam NT; Fadégnon G; Azagnandji C; Bello M; Moussiliou A; Chippaux JP; Kinde Gazard D; Massougbodji A
Malar J; 2013 Nov; 12():413. PubMed ID: 24225351
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Kayode AT; Ajogbasile FV; Akano K; Uwanibe JN; Oluniyi PE; Eromon PJ; Folarin OA; Sowunmi A; Wirth DF; Happi CT
Sci Rep; 2021 Jan; 11(1):471. PubMed ID: 33436791
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of pfdhfr and pfdhps mutations in Plasmodium falciparum associated with drug resistance among pregnant women receiving IPTp-SP at Msambweni County Referral Hospital, Kwale County, Kenya.
Gikunju SW; Agola EL; Ondondo RO; Kinyua J; Kimani F; LaBeaud AD; Malhotra I; King C; Thiong'o K; Mutuku F
Malar J; 2020 May; 19(1):190. PubMed ID: 32448228
[TBL] [Abstract][Full Text] [Related]
30. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.
Lumb V; Das MK; Singh N; Dev V; Wajihullah ; Sharma YD
Antimicrob Agents Chemother; 2009 Dec; 53(12):5173-80. PubMed ID: 19786603
[TBL] [Abstract][Full Text] [Related]
32. Two novel mutations of pfdhps K540T and I588F, affecting sulphadoxine-pyrimethamine-resistant response in uncomplicated falciparum malaria at Banjar district, South Kalimantan Province, Indonesia.
Basuki S; Fitriah ; Riyanto S; Budiono ; Dachlan YP; Uemura H
Malar J; 2014 Apr; 13():135. PubMed ID: 25187019
[TBL] [Abstract][Full Text] [Related]
33. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
[TBL] [Abstract][Full Text] [Related]
34. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of mutation in the Plasmodium falciparum dhfr and dhps genes in field isolates from Sabah, Northern Borneo.
Abdullah NR; Norahmad NA; Jelip J; Sulaiman LH; Mohd Sidek H; Ismail Z; Noedl H
Malar J; 2013 Jun; 12():198. PubMed ID: 23758930
[TBL] [Abstract][Full Text] [Related]
36. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
[TBL] [Abstract][Full Text] [Related]
37. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
[TBL] [Abstract][Full Text] [Related]
38. Temporal evolution of sulfadoxine-pyrimethamine resistance genotypes and genetic diversity in response to a decade of increased interventions against Plasmodium falciparum in northern Ghana.
Amenga-Etego LN; Asoala V; Agongo G; Jacob C; Goncalves S; Awandare GA; Rockett KA; Kwiatkowski D
Malar J; 2021 Mar; 20(1):152. PubMed ID: 33731134
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
40. Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.
Juma DW; Omondi AA; Ingasia L; Opot B; Cheruiyot A; Yeda R; Okudo C; Cheruiyot J; Muiruri P; Ngalah B; Chebon LJ; Eyase F; Johnson J; Bulimo WD; Akala HM; Andagalu B; Kamau E
Malar J; 2014 Jul; 13():250. PubMed ID: 24989984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
